These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Success in an uneven market. Russo E Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372 [No Abstract] [Full Text] [Related]
47. Chemicals from biotechnology: molecular plant genetics will challenge the chemical and the fermentation industry. Wilke D Appl Microbiol Biotechnol; 1999 Aug; 52(2):135-45. PubMed ID: 10499254 [TBL] [Abstract][Full Text] [Related]
48. Overcoming further challenges in the pharma/biotech industry: 2007 update. Graul AI; Cruces E; Revel L; Serradell N; Rosa E Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809 [TBL] [Abstract][Full Text] [Related]
50. Modern pharmaceutical biotechnology. Situation worldwide and in Germany 1995. Schlumberger HD; Stadler P Arzneimittelforschung; 1997 Jan; 47(1):106-10. PubMed ID: 9037455 [TBL] [Abstract][Full Text] [Related]
51. From bench to business and back again. Wilan K Cell; 2007 Oct; 131(2):211-3. PubMed ID: 17956718 [TBL] [Abstract][Full Text] [Related]
52. Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances. Danzon PM; Nicholson S; Pereira NS J Health Econ; 2005 Mar; 24(2):317-39. PubMed ID: 15721048 [TBL] [Abstract][Full Text] [Related]
53. Deal watch: Trends in platform technology deal-making. Walker J; Jacob J Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395 [No Abstract] [Full Text] [Related]
54. The biotechnology bubble machine. Rasnick D Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813 [No Abstract] [Full Text] [Related]
55. Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S. Dibner MD Biotechnology (N Y); 1993 Oct; 11(10):1120, 1122-3. PubMed ID: 7764092 [No Abstract] [Full Text] [Related]
56. The three pillars of bioentrepreneurship. Schoemaker HJ; Schoemaker AF Nat Biotechnol; 1998 May; 16 Suppl():13-5. PubMed ID: 9591253 [No Abstract] [Full Text] [Related]
58. Winners and losers in merger mania. Niiler E Nat Biotechnol; 1999 Nov; 17(11):1058. PubMed ID: 10545903 [No Abstract] [Full Text] [Related]
59. Biomedical technology and the clinic of the future. Nat Biotechnol; 2011 Mar; 29(3):215. PubMed ID: 21390022 [No Abstract] [Full Text] [Related]
60. Genomics and proteomics: the next generation of health care. Sica JM Empl Benefits J; 2002 Dec; 27(4):18-21. PubMed ID: 12500585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]